Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
29681-21-8
31290-76-3
53609-62-4
102867-56-1
52788-79-1
77078-22-9
461-81-4 | 1-Chloro-4-(trifluoromethoxy)benzene | AA00I8HF | MFCD00040953
4793-22-0 | 4-Chloro-2-fluoro-5-sulfamylbenzoic acid | AA00I8NS | MFCD03265327
49557-75-7 | Glycyl-l-histidyl-l-lysine | AA00I8S3 | MFCD00036754
505080-54-6 | 3-Fluoro-4-(piperidin-1-yl)benzonitrile | AA00I8ZS | MFCD03043989
51481-10-8 | Deoxynivalenol | AA00I94U | MFCD09039270
52205-73-9 | Estramustine phosphate sodium | AA00I99G | MFCD01746253
53090-43-0 | Ethyl 3-(3,4-dichlorophenyl)-3-oxopropanoate | AA00I9EG | MFCD03424830
53890-76-9 | 4-(2,4-Dichlorophenyl)phenol | AA00I9JC | MFCD11574823
545-48-2 | Erythrodiol | AA00I9NW | MFCD00017294
554407-97-5 | 2-{7-thia-9,11-diazatricyclo[6.4.0.0,2,6]dodeca-1(12),2(6),8,10-tetraen-12-ylsulfanyl}benzoic acid | AA00I9TD | MFCD03973224